ID Genomics

About:

ID Genomics specializes in nucleotide sequence-based molecular diagnostics and epidemiologic analysis of microbial pathogens.

Website: http://idgenomics.com/

Twitter/X: ID_Genomics

Top Investors: National Institutes of Health

Description:

ID Genomics specializes in nucleotide sequence-based molecular diagnostics and epidemiologic analysis of microbial pathogens. We provide fast, high-resolution, large- or small-scale clonal identification for clinical microbiology, reference and academic research laboratories, using expanded multi-locus sequence typing (MLST), genome-wide polymorphism annotation, customized phylogenetic and genomic analysis and database creation.

Total Funding Amount:

$3.35M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Seattle, Washington, United States

Founded Date:

2012-01-01

Contact Email:

info(AT)idgenomics.com

Founders:

Evgeni Sokurenko

Number of Employees:

1-10

Last Funding Date:

2021-08-24

IPO Status:

Private

Industries:

© 2025 bioDAO.ai